or
forgot password

    • cancer clinical trials in des moines, IA

    • Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma
    Raymond Blank Children's Hospital
    Des Moines, Iowa 50309
    Localized Osteosarcoma, Metastatic Osteosarcoma
    Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
    CCOP - Iowa Oncology Research Association

    Trial Locations
    CCOP - Iowa Oncology Research Association
    John Stoddard Cancer Center at Iowa Methodist Medical Center
    John Stoddard Cancer Center at Iowa Lutheran Hospital
    Mercy Capitol Hospital
    Medical Oncology and Hematology Associates at John Stoddard Cancer Center
    Medical Oncology and Hematology Associates at Mercy Cancer Center
    Mercy Cancer Center at Mercy Medical Center - Des Moines
    Metastatic Cancer, Prostate Cancer
    Octreotide in Treating Patients With Cancer-Related Malignant Ascites
    John Stoddard Cancer Center at Iowa Lutheran Hospital

    Trial Locations
    John Stoddard Cancer Center at Iowa Lutheran Hospital
    Mercy Capitol Hospital
    Medical Oncology and Hematology Associates at John Stoddard Cancer Center
    Medical Oncology and Hematology Associates at Mercy Cancer Center
    Mercy Cancer Center at Mercy Medical Center - Des Moines
    Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Medical Oncology and Hematology Associates

    Trial Locations
    Medical Oncology and Hematology Associates
    Iowa Oncology Research Association CCOP
    Mercy Capitol
    Mercy Medical Center - Des Moines
    Medical Oncology and Hematology Associates-Des Moines
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
    Medical Oncology and Hematology Associates

    Trial Locations
    Medical Oncology and Hematology Associates
    Iowa Oncology Research Association CCOP
    Mercy Capitol
    Mercy Medical Center - Des Moines
    Medical Oncology and Hematology Associates-Des Moines
    Stage I Bladder Cancer, Stage II Bladder Cancer, Stage III Bladder Cancer, Transitional Cell Carcinoma of the Bladder
    Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
    Iowa Lutheran Hospital

    Trial Locations
    Iowa Lutheran Hospital
    Medical Oncology and Hematology Associates
    Iowa Oncology Research Association CCOP
    Mercy Capitol
    Mercy Medical Center - Des Moines
    Medical Oncology and Hematology Associates-Des Moines
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Medical Oncology and Hematology Associates

    Trial Locations
    Medical Oncology and Hematology Associates
    Iowa Oncology Research Association CCOP
    Mercy Capitol
    Mercy Medical Center - Des Moines
    Medical Oncology and Hematology Associates-Des Moines
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    John Stoddard Cancer Center at Iowa Lutheran Hospital

    Trial Locations
    John Stoddard Cancer Center at Iowa Lutheran Hospital
    Medical Oncology and Hematology Associates at John Stoddard Cancer Center
    Medical Oncology and Hematology Associates at Mercy Cancer Center
    Mercy Cancer Center at Mercy Medical Center - Des Moines
    Colorectal Cancer
    Rituximab and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Non-Hodgkin's Lymphoma
    John Stoddard Cancer Center at Iowa Methodist Medical Center

    Trial Locations
    John Stoddard Cancer Center at Iowa Methodist Medical Center
    John Stoddard Cancer Center at Iowa Lutheran Hospital
    Mercy Capitol Hospital
    Medical Oncology and Hematology Associates at John Stoddard Cancer Center
    Medical Oncology and Hematology Associates at Mercy Cancer Center
    Mercy Cancer Center at Mercy Medical Center - Des Moines
    Lymphoma
    ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
    John Stoddard Cancer Center at Iowa Lutheran Hospital

    Trial Locations
    John Stoddard Cancer Center at Iowa Lutheran Hospital
    Medical Oncology and Hematology Associates at John Stoddard Cancer Center
    Medical Oncology and Hematology Associates at Mercy Cancer Center
    Mercy Cancer Center at Mercy Medical Center - Des Moines
    Cervical Cancer
    Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
    John Stoddard Cancer Center at Iowa Lutheran Hospital

    Trial Locations
    John Stoddard Cancer Center at Iowa Lutheran Hospital
    Medical Oncology and Hematology Associates at John Stoddard Cancer Center
    Medical Oncology and Hematology Associates at Mercy Cancer Center
    Mercy Cancer Center at Mercy Medical Center - Des Moines
    Prostate Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Medical Oncology and Hematology Associates

    Trial Locations
    Medical Oncology and Hematology Associates
    Iowa Oncology Research Association CCOP
    Mercy Capitol
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer